Bristol Myers Squibb says ZENBEXUS is available only via REMS program
Bristol Myers Squibb (BMY) states ZENBEXUS is available only through a restricted ZENBEXUS REMS program, with availability limited to that program’s conditions.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.